News

Cobra Biologics and the Karolinska Institutet (KI) have been awarded €3 million in emergency funding to take a DNA vaccine for Covid-19 through phase I clinical trial testing. The funding, awarded by Horizon 2020, comes as part of the OPENCORONA...

Only time will tell if any of the assays, medical equipment or drugs the U.S. FDA is approving for use during the COVID-19 pandemic under Emergency Use Authorization (EUA) will turn out to be ineffective or substandard. Now, the...

Dachser de México S.A. de C.V. (Dachser Mexico), a global logistics provider, announced that it provided air transportation of more than three million surgical and respiratory masks to Germany to help combat the spread of COVID-19. The fully loaded...

MedPharm, the leading global contract developer for topical pharmaceutical products, has quickly assembled resources in both the US and UK to produce and donate hand sanitizer to help fight the Covid-19 outbreak. The speed of the Covid-19 pandemic has put...

Johnson & Johnson is moving forward with a vaccine candidate for COVID-19. The healthcare giant said it selected a lead vaccine candidate and plans to begin human testing in September, with first batches available under potential emergency use authorization...

Two BIOCAD products, Acellbia and Herticad , received the first European registration certificate in Bosnia and Herzegovina. Registration was received with the support of ICM d.o.o partner and is valid for 5 years. The first deliveries shall start in...

Researchers in the UK have designed a portable smartphone-based coronavirus testing kit which they say can provide results for COVD-19 in just 50 minutes after taking a throat swab. Most current tests take 24-48 hours to provide results because they...